about
Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-MetMET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy.Cabozantinib for the treatment of kidney cancer.Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers.Cabozantinib: A Review in Advanced Renal Cell Carcinoma.Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation.Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.
P2860
Q33702320-E4F26A86-EAF3-4118-9C4F-E7680DFED35EQ37597858-5C2FDF40-6F39-4D07-A5AC-5B0F3337D665Q38668871-BF5C7A70-5EA4-4C8C-8B12-F93D29F5DFCAQ38668940-8D5EDA02-AE4A-4101-8158-8D695A246077Q39026733-54AEBB3A-798E-4639-952D-8F814358DABCQ50083718-15609A29-4728-4B1B-BF63-0F14C29FB78AQ52665713-2330664C-D410-4B36-930A-3C2C6B71DC1B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MET Inhibition in Clear Cell Renal Cell Carcinoma
@en
MET Inhibition in Clear Cell Renal Cell Carcinoma.
@nl
type
label
MET Inhibition in Clear Cell Renal Cell Carcinoma
@en
MET Inhibition in Clear Cell Renal Cell Carcinoma.
@nl
prefLabel
MET Inhibition in Clear Cell Renal Cell Carcinoma
@en
MET Inhibition in Clear Cell Renal Cell Carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
MET Inhibition in Clear Cell Renal Cell Carcinoma
@en
P2093
Brian Shuch
Donald P Bottaro
Harriet M Kluger
Lucia B Jilaveanu
Marta Boeke
Young H Lee
Zongzhi Liu
Zuoquan Xie
P2860
P304
P356
10.7150/JCA.14604
P577
2016-06-18T00:00:00Z